Cargando…
Homoharringtonine-Based Induction Regimen Improved the Remission Rate and Survival Rate in Chinese Childhood AML: A Report From the CCLG-AML 2015 Protocol Study
PURPOSE: Homoharringtonine (HHT) is commonly used for the treatment of Chinese adult AML, and all-trans retinoic acid (ATRA) has been verified in acute promyelocytic leukemia (APL). However, the efficacy and safety of HHT-based induction therapy have not been confirmed for childhood AML, and ATRA-ba...
Autores principales: | Li, Jing, Gao, Ju, Liu, Ansheng, Liu, Wei, Xiong, Hao, Liang, Changda, Fang, Yongjun, Dai, Yunpeng, Shao, Jingbo, Yu, Hui, Wang, Lingzhen, Wang, Li, Yang, Liangchun, Yan, Mei, Zhai, Xiaowen, Shi, Xiaodong, Tian, Xin, Ju, Xiuli, Chen, Yan, Wang, Jing, Zhang, Leping, Liang, Hui, Chen, Sen, Zhang, Jingrong, Cao, Haixia, Jin, Jiao, Hu, Qun, Wang, Junlan, Wang, Yilin, Zhou, Min, Han, Yueqin, Zhang, Rong, Zhao, Weihong, Wang, Xiaoli, Lin, Limin, Zhang, Ruidong, Gao, Chao, Xu, Liting, Zhang, Yuanyuan, Fan, Jia, Wu, Ying, Lin, Wei, Yu, Jiaole, Qi, Peijing, Huang, Pengli, Peng, Xiaoxia, Peng, Yaguang, Wang, Tianyou, Zheng, Huyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617822/ https://www.ncbi.nlm.nih.gov/pubmed/37531592 http://dx.doi.org/10.1200/JCO.22.02836 |
Ejemplares similares
-
The Metabolic Signature of AML Cells Treated With Homoharringtonine
por: Zhang, Yulong, et al.
Publicado: (2022) -
Homoharringtonine-Based Induction Therapy Reduces the Recurrence Rate of Pediatric Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
por: Wang, Bin, et al.
Publicado: (2023) -
Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study
por: Zheng, Huyong, et al.
Publicado: (2021) -
P564: HOMOHARRINGTONINE AND CYTARABINE COMBINED WITH VENETOCLAX (HAV) FOR ADULT PATIENTS WITH DE NOVO AML
por: Luo, Xiao-Hua, et al.
Publicado: (2023) -
Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial
por: Jin, Hua, et al.
Publicado: (2023)